Lamb AD, Bratt O |
Towards ""next-generation"" prostate cancer screening |
Saturday, November 14, 2015 |
The Lancet Oncology |
Motzer RJ, Hutson TE, Glen H, Michaelson MD, Molina A, Eisen T, et al. |
Lenvatinib, everolimus, and the combination in patients with metastatic ren... |
Wednesday, October 21, 2015 |
The Lancet Oncology |
Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC |
Consensus on the management of intracranial germ-cell tumours |
Wednesday, September 16, 2015 |
The Lancet Oncology |
Emma L O'Dowd, Richard W Lee , Ahsan R Akram, Emily C Bartlett, Stephe... |
Defining the road map to a UK national lung cancer screening programme |
|
The Lancet Oncology |
Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, et al. |
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorour... |
Saturday, May 16, 2015 |
The Lancet Oncology |
Treasure T, Rintoul RC, Macbeth F |
SABR in early operable lung cancer: time for evidence |
Wednesday, May 20, 2015 |
The Lancet Oncology |
Basset-Seguin N, Hauschild A, Grob JJ, Kunstfeld R, Dreno B, Mortier L, et ... |
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-p... |
Wednesday, May 20, 2015 |
The Lancet Oncology |
Valle JW, Wasan H, Lopes A, Backen AC, Palmer DH, Morris K, et al. |
Cediranib or placebo in combination with cisplatin and gemcitabine chemothe... |
Friday, July 17, 2015 |
The Lancet Oncology |
Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. |
The expanding role of primary care in cancer control |
Sunday, October 4, 2015 |
The Lancet Oncology |
Wilkins A, Mossop H, Syndikus I, Khoo V, Bloomfield D, Parker C, et al. |
Hypofractionated radiotherapy versus conventionally fractionated radiothera... |
Tuesday, November 3, 2015 |
The Lancet Oncology |